ID   PUR9_RAT                Reviewed;         592 AA.
AC   O35567; Q6IN16;
DT   09-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 2.
DT   07-APR-2021, entry version 141.
DE   RecName: Full=Bifunctional purine biosynthesis protein ATIC;
DE   AltName: Full=AICAR transformylase/inosine monophosphate cyclohydrolase;
DE            Short=ATIC;
DE   Includes:
DE     RecName: Full=Phosphoribosylaminoimidazolecarboxamide formyltransferase;
DE              EC=2.1.2.3 {ECO:0000250|UniProtKB:P31939};
DE     AltName: Full=5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase;
DE              Short=AICAR formyltransferase;
DE     AltName: Full=AICAR transformylase;
DE   Includes:
DE     RecName: Full=IMP cyclohydrolase;
DE              EC=3.5.4.10 {ECO:0000250|UniProtKB:P31939};
DE     AltName: Full=IMP synthase;
DE     AltName: Full=Inosinicase;
GN   Name=Atic; Synonyms=Purh;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Donryu; TISSUE=Liver;
RX   PubMed=9332377; DOI=10.1016/s0378-1119(97)00273-4;
RA   Akira T., Komatsu M., Nango R., Tomooka A., Konaka K., Yamauchi M.,
RA   Kitamura Y., Nomura S., Tsukamoto I.;
RT   "Molecular cloning and expression of a rat cDNA encoding 5-aminoimidazole-
RT   4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase.";
RL   Gene 197:289-293(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 178-194; 531-545 AND 570-588, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Spinal cord;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (NOV-2006) to UniProtKB.
RN   [4]
RP   FUNCTION, SUBUNIT, AND INTERACTION WITH INSR.
RX   PubMed=25687571; DOI=10.1074/mcp.m114.047159;
RA   Boutchueng-Djidjou M., Collard-Simard G., Fortier S., Hebert S.S.,
RA   Kelly I., Landry C.R., Faure R.L.;
RT   "The last enzyme of the de novo purine synthesis pathway 5-aminoimidazole-
RT   4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC)
RT   plays a central role in insulin signaling and the Golgi/endosomes protein
RT   network.";
RL   Mol. Cell. Proteomics 14:1079-1092(2015).
CC   -!- FUNCTION: Bifunctional enzyme that catalyzes the last two steps of
CC       purine biosynthesis. Acts as a transformylase that incorporates a
CC       formyl group to the AMP analog AICAR (5-amino-1-(5-phospho-beta-D-
CC       ribosyl)imidazole-4-carboxamide) to produce the intermediate formyl-
CC       AICAR (FAICAR). Can use both 10-formyldihydrofolate and 10-
CC       formyltetrahydrofolate as the formyl donor in this reaction. Also
CC       catalyzes the cyclization of FAICAR to IMP (By similarity). Promotes
CC       insulin receptor/INSR autophosphorylation and is involved in INSR
CC       internalization (PubMed:25687571). {ECO:0000250|UniProtKB:P31939,
CC       ECO:0000269|PubMed:25687571}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6S)-10-formyltetrahydrofolate + 5-amino-1-(5-phospho-beta-D-
CC         ribosyl)imidazole-4-carboxamide = (6S)-5,6,7,8-tetrahydrofolate + 5-
CC         formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide;
CC         Xref=Rhea:RHEA:22192, ChEBI:CHEBI:57453, ChEBI:CHEBI:57454,
CC         ChEBI:CHEBI:58467, ChEBI:CHEBI:58475; EC=2.1.2.3;
CC         Evidence={ECO:0000250|UniProtKB:P31939};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22193;
CC         Evidence={ECO:0000250|UniProtKB:P31939};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=10-formyldihydrofolate + 5-amino-1-(5-phospho-beta-D-
CC         ribosyl)imidazole-4-carboxamide = 5-formamido-1-(5-phospho-D-
CC         ribosyl)imidazole-4-carboxamide + 7,8-dihydrofolate;
CC         Xref=Rhea:RHEA:59144, ChEBI:CHEBI:57451, ChEBI:CHEBI:57452,
CC         ChEBI:CHEBI:58467, ChEBI:CHEBI:58475;
CC         Evidence={ECO:0000250|UniProtKB:P31939};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:59145;
CC         Evidence={ECO:0000250|UniProtKB:P31939};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + IMP = 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-
CC         carboxamide; Xref=Rhea:RHEA:18445, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:58053, ChEBI:CHEBI:58467; EC=3.5.4.10;
CC         Evidence={ECO:0000250|UniProtKB:P31939};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:18447;
CC         Evidence={ECO:0000250|UniProtKB:P31939};
CC   -!- ACTIVITY REGULATION: AMP and XMP inhibit AICAR formyltransferase
CC       activity. {ECO:0000250|UniProtKB:P31939}.
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; 5-
CC       formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-
CC       1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route):
CC       step 1/1. {ECO:0000250|UniProtKB:P31939}.
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; IMP
CC       from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step
CC       1/1. {ECO:0000250|UniProtKB:P31939}.
CC   -!- SUBUNIT: Homodimer (By similarity). Associates with internalized INSR
CC       complexes on Golgi/endosomal membranes (PubMed:25687571). Interacts
CC       with INSR; ATIC together with PRKAA2/AMPK2 and HACD3/PTPLAD1 is
CC       proposed to be part of a signaling network regulating INSR
CC       autophosphorylation and endocytosis (PubMed:25687571).
CC       {ECO:0000250|UniProtKB:P31939, ECO:0000269|PubMed:25687571}.
CC   -!- INTERACTION:
CC       O35567; PRO_0000016698 [P15127]: Insr; NbExp=3; IntAct=EBI-10768817, EBI-10768746;
CC   -!- TISSUE SPECIFICITY: Expressed in liver. {ECO:0000269|PubMed:9332377}.
CC   -!- DOMAIN: The IMP cyclohydrolase activity resides in the N-terminal
CC       region.
CC   -!- MISCELLANEOUS: The de novo purine synthesis pathway includes 10
CC       sequential steps, beginning with phosphoribosyl pyrophosphate and
CC       ending with inositol monophosphate (IMP), the first purin compound of
CC       the pathway. {ECO:0000250|UniProtKB:P31939}.
CC   -!- SIMILARITY: Belongs to the PurH family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D89514; BAA22837.1; -; mRNA.
DR   EMBL; BC072496; AAH72496.1; -; mRNA.
DR   RefSeq; NP_112276.2; NM_031014.2.
DR   SMR; O35567; -.
DR   BioGRID; 249543; 3.
DR   IntAct; O35567; 3.
DR   STRING; 10116.ENSRNOP00000021105; -.
DR   iPTMnet; O35567; -.
DR   PhosphoSitePlus; O35567; -.
DR   jPOST; O35567; -.
DR   PaxDb; O35567; -.
DR   PRIDE; O35567; -.
DR   Ensembl; ENSRNOT00000021105; ENSRNOP00000021105; ENSRNOG00000015511.
DR   GeneID; 81643; -.
DR   KEGG; rno:81643; -.
DR   UCSC; RGD:70879; rat.
DR   CTD; 471; -.
DR   RGD; 70879; Atic.
DR   eggNOG; KOG2555; Eukaryota.
DR   GeneTree; ENSGT00390000004553; -.
DR   HOGENOM; CLU_016316_3_2_1; -.
DR   InParanoid; O35567; -.
DR   OMA; WRVAKFV; -.
DR   OrthoDB; 324473at2759; -.
DR   PhylomeDB; O35567; -.
DR   TreeFam; TF105642; -.
DR   Reactome; R-RNO-73817; Purine ribonucleoside monophosphate biosynthesis.
DR   UniPathway; UPA00074; UER00133.
DR   UniPathway; UPA00074; UER00135.
DR   PRO; PR:O35567; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000015511; Expressed in thymus and 21 other tissues.
DR   Genevisible; O35567; RN.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0003937; F:IMP cyclohydrolase activity; IDA:RGD.
DR   GO; GO:0004643; F:phosphoribosylaminoimidazolecarboxamide formyltransferase activity; IDA:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0006189; P:'de novo' IMP biosynthetic process; IDA:RGD.
DR   GO; GO:0031100; P:animal organ regeneration; IEP:RGD.
DR   GO; GO:0003360; P:brainstem development; IEP:RGD.
DR   GO; GO:0098761; P:cellular response to interleukin-7; ISO:RGD.
DR   GO; GO:0021549; P:cerebellum development; IEP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0009235; P:cobalamin metabolic process; TAS:RGD.
DR   GO; GO:0046452; P:dihydrofolate metabolic process; IDA:RGD.
DR   GO; GO:0009116; P:nucleoside metabolic process; IDA:RGD.
DR   GO; GO:0010035; P:response to inorganic substance; IEP:RGD.
DR   GO; GO:0009259; P:ribonucleotide metabolic process; IDA:RGD.
DR   GO; GO:0046654; P:tetrahydrofolate biosynthetic process; IDA:RGD.
DR   Gene3D; 1.10.287.440; -; 1.
DR   Gene3D; 3.40.140.20; -; 2.
DR   Gene3D; 3.40.50.1380; -; 1.
DR   HAMAP; MF_00139; PurH; 1.
DR   InterPro; IPR024051; AICAR_Tfase_dup_dom_sf.
DR   InterPro; IPR024050; AICAR_Tfase_insert_dom_sf.
DR   InterPro; IPR016193; Cytidine_deaminase-like.
DR   InterPro; IPR011607; MGS-like_dom.
DR   InterPro; IPR036914; MGS-like_dom_sf.
DR   InterPro; IPR002695; PurH-like.
DR   PANTHER; PTHR11692; PTHR11692; 1.
DR   Pfam; PF01808; AICARFT_IMPCHas; 1.
DR   Pfam; PF02142; MGS; 1.
DR   PIRSF; PIRSF000414; AICARFT_IMPCHas; 1.
DR   SMART; SM00798; AICARFT_IMPCHas; 1.
DR   SMART; SM00851; MGS; 1.
DR   SUPFAM; SSF52335; SSF52335; 1.
DR   SUPFAM; SSF53927; SSF53927; 1.
DR   TIGRFAMs; TIGR00355; purH; 1.
DR   PROSITE; PS51855; MGS; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Direct protein sequencing; Hydrolase; Multifunctional enzyme;
KW   Purine biosynthesis; Reference proteome; Transferase.
FT   CHAIN           1..592
FT                   /note="Bifunctional purine biosynthesis protein ATIC"
FT                   /id="PRO_0000270214"
FT   DOMAIN          1..146
FT                   /note="MGS-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01202"
FT   NP_BIND         12..14
FT                   /note="IMP"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   NP_BIND         34..37
FT                   /note="IMP"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   NP_BIND         64..67
FT                   /note="IMP"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   NP_BIND         101..102
FT                   /note="IMP"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   NP_BIND         125..126
FT                   /note="IMP"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   REGION          1..198
FT                   /note="IMP cyclohydrolase"
FT                   /evidence="ECO:0000250|UniProtKB:P31335"
FT   REGION          199..592
FT                   /note="AICAR formyltransferase"
FT                   /evidence="ECO:0000250|UniProtKB:P31335"
FT   REGION          207..208
FT                   /note="AICAR binding"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   REGION          565..566
FT                   /note="10-formyltetrahydrofolate binding"
FT                   /evidence="ECO:0000250|UniProtKB:P31335"
FT   ACT_SITE        137
FT                   /note="Proton donor/acceptor; for FAICAR cyclization
FT                   activity"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   ACT_SITE        267
FT                   /note="Proton acceptor; for AICAR formyltransferase
FT                   activity"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   BINDING         267
FT                   /note="AICAR"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   BINDING         316
FT                   /note="AICAR; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   BINDING         339
FT                   /note="AICAR"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   BINDING         431
FT                   /note="AICAR; shared with dimeric partner"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   BINDING         451
FT                   /note="AICAR; shared with dimeric partner"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   BINDING         452
FT                   /note="10-formyltetrahydrofolate; via amide nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:P31335"
FT   BINDING         541
FT                   /note="AICAR; via carbonyl oxygen; shared with dimeric
FT                   partner"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   BINDING         546
FT                   /note="10-formyltetrahydrofolate"
FT                   /evidence="ECO:0000250|UniProtKB:P31335"
FT   BINDING         588
FT                   /note="AICAR; shared with dimeric partner"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   SITE            266
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   MOD_RES         199
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P31939"
FT   CONFLICT        24
FT                   /note="L -> H (in Ref. 1; BAA22837)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   592 AA;  64208 MW;  D9D710794BB12B95 CRC64;
     MASSQLALFS VSDKTGLVEF ARNLASLGLS LVASGGTAKA IRDAGLAVRD VSELTGFPEM
     LGGRVKTLHP AVHAGILARN IPEDAADMAR LDFNLIRVVV CNLYPFVKTV ASPDVTVEAA
     VEQIDIGGVT LLRAAAKNHA RVTVVCEPED YGAVAAEMQG SGNKDTSLET RRHLALKAFT
     HTAQYDEAIS DYFRRQYSKG ISQMPLRYGM NPHQTPAQLY TLKPKLPITV LNGAPGFINL
     CDALNAWQLV TELRGAVDIP AAASFKHVSP AGAAVGVPLS EDEARVCMVY DLYPTLTPLA
     IAYARARGAD RMSSFGDFVA LSDVCDVPTA KIISREVSDG IVAPGYEEEA LKILSKKKNG
     SYCVLQMDQS YKPDENEVRT LFGLRLSQKR NNGVVDKSLF SNIVTKNKDL PESALRDLIV
     ATIAVKYTQS NSVCYAKDGQ VIGIGAGQQS RIHCTRLAGD KANSWWLRHH PRVLSMKFKA
     GVKRAEVSNA IDQYVTGTIG EGEDLVKWKA LFEEVPELLT EAEKKEWVDK LSGVSVSSDA
     FFPFRDNVDR AKRSGVAYIV APSGSTADKV VIEACDELGI VLAHTDLRLF HH
//
